Steve Melchiode is the current president at SpineSmith USA. Steve was a founding member of Celling Biosciences first enterprise, Spinesmith. Spinesmith is a biotech company that specializes in biomaterials science and biological systems for the treatment of spinal pathologies. They were one of the first medical device companies to focus on biological enhanced devices. Steve has been with the company since January 2006 and became president in December 2006.
Steve Melchiode earned a Bachelor of Arts in Marketing from The University of Alabama.
Steve Melchiode reports to Kevin Dunworth, CEO. Steve Melchiode works with Dru Dunworth - General Manager, Blair Duncan - CFO & COO.
Sign up to view 0 direct reports
Get started